Advised the board on the legal ramifications under the Bribery Act, Fraud Act and POCA involving huge reputational impact for the client.
Construction company
On the data protection aspects of its audits, including the processing of health-related data and the interplay with other regulatory requirements in the context of medicine provision.
Biopharmaceutical company
On carrying out the governance review and related interaction with the funders of a major research centre, with a view to securing the Phase 2 funding.
Major Scottish University
On the implementation of their firm and product wide ESG strategy.
Delancey
Quilter Investors
Tailored workshops for legal and business teams covering the European Green Deal, the UK Net Zero Strategy, extended producer responsibility developments, ESG, packaging and waste, deposit return schemes and single use plastics.
FMCG company
On the implementation of upcoming sustainable investment legislation.
On the implementation of upcoming sustainable investment legislation.
On its compliance with environmental regulations and legislation across its physical business operations within the UK and Republic of Ireland. This strategic project assessed the environmental and climate change issues they are exposed to.
Major UK financial institution
On new governance arrangements to authorise Oil Spill Response services.
Multinational energy company
On its daily corporate governance matters, including the change of company name and expanding of business scope, as well as regulatory matters.
Pharmaceutical company
On its compliance with environmental regulations and legislation across its physical business operations within the United Kingdom and the Republic of Ireland. This strategic project asses the wide range of environmental and climate change issues that they are exposed to.
Major UK financial institution
On new governance arrangements to authorise Oil Spill Response services.
Multinational energy company
On its daily corporate governance matters, including the change of company name and expanding of business scope, as well as regulatory matters.
Pharmaceutical company